Glaxosmithkline Consumer Healthcare Holdings DBA Haleon recalls Advil Liqui Gels, Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules

Recalled February 1, 2023 · FDA recall D-0182-2023 · Glaxosmithkline Consumer Healthcare Holdings

Hazard

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back · FDA Class I

Units

88,380 capsules

Sold at

Nationwide in the USA.

Description

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Product

Advil Liqui Gels, Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Distributed by: Pfizer, Madison, NJ 07940, UPC 3 0573 0169 49 3

Manufacturer(s)

Glaxosmithkline Consumer Healthcare Holdings DBA Haleon

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →